BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $170 | -59.2% | 4,484 | -51.0% | 0.00% | -100.0% |
| Q2 2023 | $417 | +169.0% | 9,151 | +139.9% | 0.00% | – |
| Q1 2023 | $155 | -53.5% | 3,814 | -41.8% | 0.00% | -100.0% |
| Q4 2022 | $333 | -100.0% | 6,554 | -58.7% | 0.00% | -50.0% |
| Q3 2022 | $854,000 | -7.0% | 15,860 | +11.0% | 0.00% | 0.0% |
| Q2 2022 | $918,000 | -11.6% | 14,293 | +6.6% | 0.00% | 0.0% |
| Q1 2022 | $1,039,000 | +6.9% | 13,408 | +18.5% | 0.00% | 0.0% |
| Q4 2021 | $972,000 | +43.6% | 11,319 | +34.6% | 0.00% | +100.0% |
| Q3 2021 | $677,000 | -12.9% | 8,411 | -12.8% | 0.00% | -50.0% |
| Q2 2021 | $777,000 | -17.1% | 9,645 | -13.1% | 0.00% | 0.0% |
| Q1 2021 | $937,000 | -49.0% | 11,101 | -51.5% | 0.00% | -60.0% |
| Q4 2020 | $1,837,000 | -97.6% | 22,880 | -97.6% | 0.01% | -97.8% |
| Q3 2020 | $76,797,000 | -34.4% | 954,952 | -29.8% | 0.23% | -38.6% |
| Q2 2020 | $117,087,000 | +8.3% | 1,359,884 | +2.1% | 0.37% | -15.1% |
| Q1 2020 | $108,142,000 | +3740.3% | 1,331,960 | +3854.6% | 0.44% | +4744.4% |
| Q4 2019 | $2,816,000 | -99.3% | 33,681 | -99.2% | 0.01% | -99.3% |
| Q3 2019 | $376,786,000 | -1.6% | 4,307,606 | -7.9% | 1.34% | +4.3% |
| Q2 2019 | $382,917,000 | +0.5% | 4,675,424 | -0.2% | 1.29% | -11.8% |
| Q1 2019 | $381,086,000 | +37.1% | 4,686,835 | +11.0% | 1.46% | +20.9% |
| Q4 2018 | $277,879,000 | -5.4% | 4,221,831 | +10.8% | 1.21% | +10.7% |
| Q3 2018 | $293,682,000 | +5.0% | 3,809,617 | +0.6% | 1.09% | +0.8% |
| Q2 2018 | $279,584,000 | +13.7% | 3,786,353 | +0.1% | 1.08% | +13.3% |
| Q1 2018 | $245,986,000 | +1.3% | 3,782,068 | +0.6% | 0.96% | +1.5% |
| Q4 2017 | $242,922,000 | -17.9% | 3,758,095 | -20.3% | 0.94% | -20.2% |
| Q3 2017 | $296,048,000 | +5.1% | 4,717,899 | +1.4% | 1.18% | +4.1% |
| Q2 2017 | $281,690,000 | +50112.1% | 4,652,950 | +42907.2% | 1.14% | +56650.0% |
| Q1 2017 | $561,000 | -98.9% | 10,819 | -99.1% | 0.00% | -99.2% |
| Q4 2016 | $52,794,000 | -6.8% | 1,190,683 | +0.0% | 0.24% | -14.7% |
| Q3 2016 | $56,656,000 | +5.3% | 1,190,250 | +0.0% | 0.28% | -3.4% |
| Q2 2016 | $53,805,000 | +56.8% | 1,189,828 | +42.5% | 0.30% | +52.1% |
| Q1 2016 | $34,307,000 | -63.4% | 835,118 | -66.0% | 0.19% | -62.8% |
| Q4 2015 | $93,748,000 | +16.5% | 2,457,331 | +0.3% | 0.52% | +13.5% |
| Q3 2015 | $80,496,000 | -51.6% | 2,450,430 | +3.0% | 0.46% | -47.1% |
| Q2 2015 | $166,409,000 | -7.7% | 2,379,632 | -9.6% | 0.87% | -4.9% |
| Q1 2015 | $180,251,000 | +47.8% | 2,631,409 | +58.1% | 0.91% | +39.1% |
| Q4 2014 | $121,946,000 | -27.7% | 1,663,881 | -29.2% | 0.66% | +30.4% |
| Q3 2014 | $168,648,000 | +106.7% | 2,349,868 | +108.3% | 0.50% | +0.6% |
| Q2 2014 | $81,573,000 | +36.5% | 1,128,249 | +38.9% | 0.50% | +24.3% |
| Q1 2014 | $59,762,000 | +632.6% | 812,188 | +592.5% | 0.40% | +594.8% |
| Q4 2013 | $8,158,000 | +17.7% | 117,288 | +11.2% | 0.06% | +3.6% |
| Q3 2013 | $6,930,000 | -4.8% | 105,473 | +0.4% | 0.06% | -13.8% |
| Q2 2013 | $7,276,000 | – | 105,043 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |